world
Ivermectin Gains Following Among Some Cancer Patients
Ivermectin, once promoted during the pandemic for COVID-19 without proven results, has drawn new interest from certain cancer patients. Reports indicate growing inquiries to doctors about its potential use against cancer.
AB
app.buzzsumo.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Ivermectin, previously promoted during the pandemic for COVID-19 despite lacking proven effectiveness, has drawn interest from some cancer patients seeking alternative treatments.
Some cancer patients are turning to ivermectin outside standard protocols. Doctors report receiving questions about its possible anti-cancer properties. Medical organizations continue to advise against using ivermectin for cancer treatment until clinical evidence establishes safety and results.
During the pandemic, ivermectin gained popularity based on claims of benefit for COVID-19 that later lacked scientific support. Health agencies issued warnings against its use for that purpose at the time. Current patient inquiries reflect a similar pattern of exploring unverified applications for the drug.
Transparency
1 source · single source
CorroborationLimited · 1 source
